Stifel resumed coverage of Alphatec (ATEC) with a Buy rating and $20 price target Alphatec stood out in the firm’s U.S. spine surgeon survey as the fastest expected share gainer, giving the firm confidence in the company’s “beat-and-raise playbook,” the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC: